v3.22.2.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020 65,971        
Beginning balance at Dec. 31, 2020 $ 247,041        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Preferred stock conversion to Class B common stock (in shares) (65,971)        
Preferred stock conversion to Class B common stock $ (247,041)        
Ending balance (in shares) at Mar. 31, 2021 0        
Ending balance at Mar. 31, 2021 $ 0        
Beginning balance (in shares) at Dec. 31, 2020   12,890      
Beginning balance at Dec. 31, 2020 (222,177) $ 1 $ 29,989 $ 0 $ (252,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,458      
Exercise of stock options 1,875   1,875    
Stock-based compensation 3,498   3,498    
Conversion of preferred stock warrants to Class B common stock warrants 1,827   1,827    
Preferred stock conversion to Class B common stock (in shares)   65,971      
Preferred stock conversion to Class B common stock 247,041 $ 7 247,034    
Sale of Class A common stock upon initial public offering, net of issuance costs (in shares)   13,800      
Sale of Class A common stock upon initial public offering, net of issuance costs 175,534 $ 1 175,533    
Cashless exercise of common stock warrant (in shares)   25      
Net loss (16,171)       (16,171)
Ending balance (in shares) at Mar. 31, 2021   94,144      
Ending balance at Mar. 31, 2021 $ 191,427 $ 9 459,756 0 (268,338)
Beginning balance (in shares) at Dec. 31, 2020 65,971        
Beginning balance at Dec. 31, 2020 $ 247,041        
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Beginning balance (in shares) at Dec. 31, 2020   12,890      
Beginning balance at Dec. 31, 2020 (222,177) $ 1 29,989 0 (252,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income (28)        
Net loss (45,265)        
Ending balance (in shares) at Sep. 30, 2021   97,328      
Ending balance at Sep. 30, 2021 $ 215,674 $ 10 513,124 (28) (297,432)
Beginning balance (in shares) at Mar. 31, 2021 0        
Beginning balance at Mar. 31, 2021 $ 0        
Ending balance (in shares) at Jun. 30, 2021 0        
Ending balance at Jun. 30, 2021 $ 0        
Beginning balance (in shares) at Mar. 31, 2021   94,144      
Beginning balance at Mar. 31, 2021 191,427 $ 9 459,756 0 (268,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   525      
Exercise of stock options 959   959    
Stock-based compensation 2,896   2,896    
Issuance of common stock to settle restricted stock units (in shares)   8      
Cashless exercise of common stock warrant (in shares)   104      
Withholding taxes for the net share settlement of restricted stock units (in shares)   (1)      
Withholding taxes for the net share settlement of restricted stock units (29)   (29)    
Other comprehensive (loss) income (36)     (36)  
Net loss (14,379)       (14,379)
Ending balance (in shares) at Jun. 30, 2021   94,780      
Ending balance at Jun. 30, 2021 $ 180,838 $ 9 463,582 (36) (282,717)
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   534      
Exercise of stock options 1,023   1,023    
Stock-based compensation 2,995   2,995    
Issuance of common stock to settle restricted stock units (in shares)   14      
Sale of Class A common stock upon initial public offering, net of issuance costs (in shares)   2,000      
Sale of Class A common stock upon initial public offering, net of issuance costs 45,525 $ 1 45,524    
Other comprehensive (loss) income 8     8  
Net loss (14,715)       (14,715)
Ending balance (in shares) at Sep. 30, 2021   97,328      
Ending balance at Sep. 30, 2021 $ 215,674 $ 10 513,124 (28) (297,432)
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 98,435 98,435      
Beginning balance at Dec. 31, 2021 $ 205,734 $ 10 522,161 (1,094) (315,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   334      
Exercise of stock options 754   754    
Stock-based compensation 3,618   3,618    
Issuance of common stock to settle restricted stock units (in shares)   173      
Other comprehensive (loss) income (1,710)     (1,710)  
Net loss (20,708)       (20,708)
Ending balance (in shares) at Mar. 31, 2022   98,942      
Ending balance at Mar. 31, 2022 $ 187,688 $ 10 526,533 (2,804) (336,051)
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Sep. 30, 2022 0        
Ending balance at Sep. 30, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 98,435 98,435      
Beginning balance at Dec. 31, 2021 $ 205,734 $ 10 522,161 (1,094) (315,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) income (6,542)        
Net loss $ (72,785)        
Ending balance (in shares) at Sep. 30, 2022 100,732 100,732      
Ending balance at Sep. 30, 2022 $ 149,695 $ 10 545,449 (7,636) (388,128)
Beginning balance (in shares) at Mar. 31, 2022 0        
Beginning balance at Mar. 31, 2022 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Mar. 31, 2022   98,942      
Beginning balance at Mar. 31, 2022 187,688 $ 10 526,533 (2,804) (336,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   160      
Exercise of stock options 874   874    
Stock-based compensation 10,353   10,353    
Issuance of common stock to settle restricted stock units (in shares)   685      
Issuance of common stock from employee stock purchase plan (in shares)   166      
Other comprehensive (loss) income (2,587)     (2,587)  
Net loss (28,399)       (28,399)
Ending balance (in shares) at Jun. 30, 2022   99,953      
Ending balance at Jun. 30, 2022 $ 167,929 $ 10 537,760 (5,391) (364,450)
Ending balance (in shares) at Sep. 30, 2022 0        
Ending balance at Sep. 30, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   139      
Exercise of stock options 229   229    
Stock-based compensation 7,460   7,460    
Issuance of common stock to settle restricted stock units (in shares)   640      
Other comprehensive (loss) income (2,245)     (2,245)  
Net loss $ (23,678)       (23,678)
Ending balance (in shares) at Sep. 30, 2022 100,732 100,732      
Ending balance at Sep. 30, 2022 $ 149,695 $ 10 $ 545,449 $ (7,636) $ (388,128)